Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹18 Cr₹10 Cr₹6.17 Cr₹2.00 Cr₹5.00 Cr

What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS is ₹18 Cr based on Mar2024 Standalone results.
Year Contingent Liabilities
Mar2024₹18 Cr
Mar2023₹10 Cr
Mar2022₹6.17 Cr
Mar2021₹2.00 Cr
Mar2020₹5.00 Cr

How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2024 ₹18 Cr
67.43
Mar2023 ₹10 Cr
69.85
Mar2022 ₹6.17 Cr
208.45
Mar2021 ₹2.00 Cr
-60.00
Mar2020 ₹5.00 Cr -

Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹182.3 Cr 7.3% 5.3% -23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

7.3%

5.3%

-23.2%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses